多参数MRI联合PSMA PET/CT能否提高前列腺癌根治术后生化复发诊断准确性?
该研究纳入2016至2020年间117例根治术后生化复发患者,共150组配对扫描,比较mpMRI与68Ga-PSMA PET/CT对局部复发和远处转移的检出率。结果显示mpMRI对局部复发检出率更高,PSMA PET/CT对远处转移检出率更高,PSA速度是两种影像学复发的显著预测因子,联合应用可能改善复发病灶诊断与治疗选择。
要点
- mpMRI对局部复发检出率高于PSMA PET/CT,尤其在PSA<0.5 ng/mL时。
- PSMA PET/CT对远处转移检出率高于mpMRI。
- PSA速度是两种影像学复发的显著预测因子。
核心结论
- mpMRI对局部复发检出率更高,68Ga-PSMA PET/CT对远处转移检出率更高。
- PSA速度是两种影像学局部复发和远处转移的显著预测因子。
- 联合mpMRI与68Ga-PSMA PET/CT可能改善复发病灶诊断和治疗选择。
研究设计与样本
- 回顾性分析2016至2020年根治术后生化复发患者。
- 共117例患者接受150组配对扫描,PSA阈值为0.2、0.5和1.0 ng/mL。
- 采用Kaplan-Meier分析和多因素回归分析。
主要发现
- PSMA PET/CT在PSA<0.2、0.2-0.5、0.5-1.0和>1.0 ng/mL时远处转移检出率分别为6.1%、10%、25%和36%,mpMRI分别为3%、6.7%、6.3%和24%。
- mpMRI在相同PSA区间局部复发检出率分别为30.3%、33.3%、40.6%和40%,PSMA PET/CT分别为0%、13.3%、18.8%和32%。
- PSA<0.2和0.2-0.5 ng/mL时mpMRI局部复发检出率显著高于PSMA(P<0.001和P=0.001)。
- PSA 0.5-1.0 ng/mL时PSMA远处转移检出率显著高于MRI(P=0.039)。
- 多因素分析显示PSA速度是MRI、PSMA及联合结果中局部复发和远处转移的显著预测因子,ISUP分级是MRI远处转移的显著预测因子。
临床怎么用
- 生化复发后可根据PSA水平选择影像学检查:低PSA时mpMRI有助于发现局部复发,较高PSA时PSMA PET/CT有助于发现远处转移。
- 联合mpMRI与PSMA PET/CT可能提高复发病灶检出并辅助治疗决策。
- PSA速度可作为预测影像学复发的重要参考指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To analyse the utility of adding multiparametric magnetic resonance imaging (mpMRI) with 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in detection of local recurrence (LR) and distant recurrence (DR) in patients with biochemical recurrence (BCR), by describing detection rates over time since radical prostatectomy (RP), describing detection rates at differing prostate-specific antigen (PSA) intervals, and identifying clinicopathological factors that predict detection of recurrence on imaging. PATIENTS AND METHODS: Patients with BCR after RP were identified from 2016 to 2020. Kaplan-Meier analysis was performed for LR and DR on mpMRI, 68Ga-PSMA PET/CT, and paired/combined scans, and multivariate regression was performed identifying predictors of LR and DR. RESULTS: A total of 117 patients underwent 150 sets of paired scans for BCR after RP, at PSA thresholds 0.2, 0.5, and 1.0 ng/mL. The 68Ga-PSMA PET/CT had higher detection rates of DR at PSA levels of <0.2, 0.2-0.5, 0.5-1.0, and >1.0 ng/mL vs mpMRI (6.1%, 10%, 25% and 36% vs 3%, 6.7%, 6.3%, and 24%, respectively). Meanwhile, mpMRI had higher detection rate of LR than 68Ga-PSMA PET/CT (30.3%, 33.3%, 40.6%, and 40% vs 0%, 13.3%, 18.8%, and 32%, respectively). The detection rate for LR was significantly higher on MRI compared to PSMA at PSA levels of <0.2 and 0.2-0.5 ng/mL (P < 0.001 and P = 0.001, respectively). The detection rate for DR was significantly higher on PSMA than MRI at PSA levels of 0.5-1.0 ng/mL (P = 0.039). On multivariate analysis, PSA velocity was a statistically significant predictor of both LR and DR on MRI alone, PSMA alone, and combined results of paired PSMA and MRI, and International Society of Urological Pathology grade was a statistically significant predictor of DR on MRI. CONCLUSION: The mpMRI had a higher detection rate for LR, while 68Ga-PSMA PET/CT had a higher detection rate for DR. PSA velocity was a significant predictor of both LR and DR on both imaging modalities. In BCR after RP, addition of mpMRI with 68Ga-PSMA PET/CT may improve diagnosis of recurrent lesions and patient selection for treatment.
引用
- Khanna Y, Chinni V, Gnanasambantham K, et al. Does addition of multiparametric MRI to PSMA PET/CT improve diagnostic accuracy for biochemical recurrence after radical prostatectomy? BJU Int. 2026. PMID: 41504471. doi:10.1111/bju.70115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。